Jane He, General Partner of YZi Labs, said that Binance founder Changpeng “CZ” Zhao’s dedication to biotech investing is driven by his commitment to supporting overlooked innovators and prioritizing people. The statement was made during an interview.
“CZ listened more than he spoke, scribbling notes, his curiosity as genuine as his resolve,” said He. “For him, investing in biotech is an act of defiance, a way to open doors for the dreamers. He believes that fairness and innovation aren’t mutually exclusive, that you can build something ambitious without losing sight of the people it’s meant to serve. CZ makes me believe that we are building something that feels more like a movement than a fund.”
The biotechnology and healthcare investment landscape in 2024 has experienced a resurgence in venture capital funding, particularly for early-stage companies. According to Investopedia, after a downturn in 2023, the sector has seen renewed interest with significant capital inflows supporting innovation in areas such as AI-driven drug discovery and personalized medicine. This revival is attributed to advancements in technology, favorable regulatory changes, and a growing demand for innovative healthcare solutions. Analysts note that while challenges remain, the current trend indicates a positive outlook for biotech investments.
Changpeng Zhao, commonly known as CZ, is recognized as a prominent entrepreneur and investor for his leadership in the global cryptocurrency industry. He founded Binance and served as its CEO until recently. Under his guidance, Binance became the world’s largest cryptocurrency exchange by trading volume. According to Forbes, CZ is widely credited with promoting blockchain innovation and increasing access to digital assets worldwide, earning him a reputation as one of the most influential figures in fintech.
Jane He leads YZi Labs’ biotech investment initiatives as General Partner. Before joining YZi Labs, she was Chief Operating Officer at a Hong Kong-based hedge fund focusing on growth-stage investments in biotechnology and innovation-driven sectors. She holds an MBA from Stanford Graduate School of Business with a specialization in healthcare technologies.
YZi Labs, formerly known as Binance Labs, is based in Hong Kong and focuses on ventures within Web3, artificial intelligence (AI), and biotechnology. Established in 2018, the firm operates as a family office managing approximately $10 billion in assets. YZi Labs aims to empower visionary founders by providing capital and strategic support to projects with long-term impact across its areas of focus.
